IMG-20251212-WA0011 - Doctor Dyar

Modern Evidence-Based Approaches for the Management of Persistent and Recurrent Vaginitis

Laboratorio Elea, a leading Argentine pharmaceutical company, successfully organized an educational scientific meeting for gynecologists in Mosul, held at the White Tower Hotel. The event focused on “Modern Evidence-Based Approaches for the Management of Persistent and Recurrent Vaginitis,” addressing one of the most challenging and frequently encountered conditions in gynecological practice.

The session provided an in-depth review of the latest international and CDC recommendations, with particular emphasis on long-term maintenance therapy for recurrent cases. Experts highlighted the clinical importance of twice-weekly vaginal suppository regimens administered over a period of 3 to 6 months to reduce recurrence rates and improve patient quality of life.

The discussion also reinforced the continued role of metronidazole as a first-line therapeutic option, noting its proven efficacy in controlling infection while preserving the normal vaginal microbiota, especially Lactobacillus species. Through evidence-based insights and practical clinical guidance, the event aimed to support physicians in optimizing treatment strategies and achieving better outcomes for patients suffering from recurrent vaginal infections.

  • Date: December 11, 2025
  • Time: 08:00 PM
  • Venue: White Tower Hotel
  • Location: Mosul, Iraq
  • Address: Near Super Qi Banking Service
photo_2025-12-13_22-25-08

XenoFarma Participates in World Diabetes Day Event in Kirkuk — Introducing Innofer 10 and 20 to Pediatric Specialists

XenoFarma (Emergopharm) marketing and sales team proudly participated in the World Diabetes Day event held at Azadi Teaching Hospital in Kirkuk. The meeting brought together pediatric specialists to discuss key challenges associated with diabetes management in children.

During the event, our team delivered an informative session on anemia in patients with diabetes, highlighting its impact on overall health and quality of life. We also introduced Innofer 10 & 20, emphasizing their clinical relevance, efficacy, and role in managing iron deficiency among patients with chronic conditions.

This engagement reflects XenoFarma’s commitment to supporting healthcare professionals with high-quality products and evidence-based medical education. We thank the pediatric specialists in Kirkuk for their participation and valuable discussions.

Date: January 12, 2025 – 9:00 AM
Location: Azadi Teaching Hospital, Kirkuk
Venue: Main Meeting Room

IMG-20251102-WA0031

XenoFarma Sponsors Specialized Training on International Medical Device Regulations – Erbil, November 2024

XenoFarma Pharmaceutical Company is proud to sponsor an advanced training program titled “Regulatory Affairs of Medical Devices: International Perspective (Europe & KSA)”, held on November 28–29, 2024, at the Canyon Hotel, Erbil.

The two-day course, organized in collaboration with RADEX for Regulatory Affairs Consultation, will feature expert instructors Ms. Asma Abu-Staiteh, MSc in Regulatory Affairs and CEO of RADEX, and Ms. Batoul Omar Al-Ajarmeh, RADEX Training Manager and Bachelor of Pharmacy.

This intensive training aims to provide participants with comprehensive insights into the regulatory frameworks governing medical devices across Europe and Saudi Arabia, empowering attendees with the knowledge and skills necessary for successful regulatory compliance and market access.

DSC06540

Erbil Urology Meeting Highlights Advancements in Laser Technology and Brand Innovation / Erbil, February 2025 – XenoFarma proudly participated in the Erbil Urology

Erbil, February 2025 – XenoFarma proudly participated in the Erbil Urology Meeting, an important scientific gathering bringing together leading experts in the field of urology.

The event featured a remarkable presentation by Dr. Mostafa Othman, who discussed the role of laser technology in ureteric stone management, shedding light on the latest innovations and clinical applications that are transforming patient outcomes.

The session was expertly moderated by Assistant Professor Nihad Jawad, ensuring a dynamic exchange of knowledge among specialists and attendees.

As part of the program, XenoFarma delivered an insightful presentation on Linus Duo, highlighting its role and positioning within the ELEA product portfolio. The session reinforced XenoFarma’s commitment to advancing healthcare solutions and supporting medical professionals with trusted and innovative products.

XenoFarma extends its appreciation to all participants and organizers for making this event a success and looks forward to continued collaboration in advancing medical excellence in Iraq.

272888097_1619990528340339_1944431362108870071_n

Workshop for Emergency Doctors in Erbil and Sulaimani

Under the supervision of Emergency Medical Association in Kurdistan and in cooperation with the international organization one vision international and the company XenoFarma, a three-day workshop has held for emergency doctors in Erbil and Sulaimani on these subjects.

  • Advanced cardiac life support
  • Advanced pediatric life support

It was conducted and at the end of the semester, the international certificate was presented to the participants of the semester.